Dehydrocostus lactone alleviates atherosclerosis by promoting cholesterol efflux and inhibiting inflammation via the TLR2/PPAR-γ/NF-κB signaling pathway in both in vivo and in vitro models. Here, NFKB1 is linked to atherosclerosis.